Cell profiling

#Cancer research #Cell profiling #Drug development #Financing #Next generation sequencing #One Biosciences

€15 million to advance clinical single cell profiling

One Biosciences has raised €15 million in Series A financing to advance its clinical grade single-cell tumour transcriptomic profiling capabilities. The financing was led by Redmile Group and Blast, with participation from Galion.exe, Invus, Adamed Technology, Sofinnova Partners, Polytechnique Ventures, and Kima Ventures. This round brings One Biosciences’ total funding… Read More

#Business & Investment #News